Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD)
- Conditions
- Macular Degeneration
- Registration Number
- NCT00078221
- Lead Sponsor
- OccuLogix
- Brief Summary
AMD is a progressive disease of the retina which is nourished by a network of tiny blood vessels. There is evidence to suggest that the flow of nutrients to the retina is impaired in patients with AMD. Rheopheresis blood filtration uses blood filters that deplete excesses of large proteins, fats and other substances from the blood, improving blood flow to the macula, potentially improving vision.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 180
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (8)
Retina Vitreous Associates
🇺🇸Beverly Hills, California, United States
Aran Eye Associates
🇺🇸Coral Gables, Florida, United States
Retina Health Care
🇺🇸Ft. Myers, Florida, United States
UIC Eye Center
🇺🇸Chicago, Illinois, United States
Macula Care
🇺🇸New York, New York, United States
Carolina Eye Associates
🇺🇸Southern Pines, North Carolina, United States
Associated Retinal Consultants
🇺🇸Bala Cynwyd, Pennsylvania, United States
W. Bradley Kates, MD
🇨🇦Oakville,, Ontario, Canada
Retina Vitreous Associates🇺🇸Beverly Hills, California, United States